Circadian Metabolic Reprogramming Therapy

Target: SIRT1/PRKAA1/PPARGC1A Composite Score: 0.455 Price: $0.52▲6.0% Citation Quality: Pending chronobiology Status: active
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
📄 Export → LaTeX
Select venue
arXiv Preprint NeurIPS Nature Methods PLOS ONE
🌐 Open in Overleaf →
📖 Export BibTeX
✓ All Quality Gates Passed
Evidence Strength Pending (0%)
5
Citations
1
Debates
5
Supporting
2
Opposing
Quality Report Card click to collapse
C
Composite: 0.455
Top 73% of 1875 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
C+ Mech. Plausibility 15% 0.50 Top 76%
C+ Evidence Strength 15% 0.50 Top 57%
C+ Novelty 12% 0.50 Top 82%
C+ Feasibility 12% 0.50 Top 65%
F Impact 12% 0.00 Top 50%
C+ Druggability 10% 0.50 Top 57%
C+ Safety Profile 8% 0.50 Top 57%
C+ Competition 6% 0.50 Top 77%
C+ Data Availability 5% 0.50 Top 71%
C+ Reproducibility 5% 0.50 Top 63%
Evidence
5 supporting | 2 opposing
Citation quality: 43%
Debates
1 session A+
Avg quality: 0.95
Convergence
0.00 F 6 related hypothesis share this target

From Analysis:

Can circadian interventions reverse microglial priming independent of sleep disruption effects?

The debate highlighted that sleep disruption affects multiple systems simultaneously, creating confounding variables. Isolating direct circadian effects on microglia from indirect sleep-related mechanisms is crucial for therapeutic specificity. Source: Debate session sess_SDA-2026-04-04-gap-neuroinflammation-microglial-20260404 (Analysis: SDA-2026-04-04-gap-neuroinflammation-microglial-20260404)

→ View full analysis & debate transcript

Description

Timed delivery of NAD+ precursors and AMPK activators to reset microglial circadian metabolism from glycolytic pro-inflammatory to oxidative anti-inflammatory phenotypes

No AI visual card yet

Curated Mechanism Pathway

Curated pathway diagram from expert analysis

flowchart TD
    A["Microglial Circadian Disruption
Glycolytic Pro-Inflammatory Shift"] B["NAD+ Depletion
SIRT1 SIRT3 Activity Impaired"] C["AMPK PRKAA1 Signaling Reduced
Oxidative Metabolism Brake"] D["Timed NAD+ Precursor Delivery
NMN NR at Circadian Peak"] E["AMPK Activator Administration
AICAR Metformin at Trough"] F["Sirtuin Reactivation
SIRT1 Deacetylase Restored"] G["PPARGC1A PGC1alpha Deacetylated
Oxidative Phosphorylation Restored"] H["Anti-Inflammatory Microglial Phenotype
Homeostatic Circadian Metabolism"] A --> B A --> C D --> F E --> C B --> F C --> G F --> G G --> H style G fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7 style H fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.50 (15%) Evidence 0.50 (15%) Novelty 0.50 (12%) Feasibility 0.50 (12%) Impact 0.00 (12%) Druggability 0.50 (10%) Safety 0.50 (8%) Competition 0.50 (6%) Data Avail. 0.50 (5%) Reproducible 0.50 (5%) KG Connect 0.50 (8%) 0.455 composite
7 citations 7 with PMID 5 medium Validation: 43% 5 supporting / 2 opposing
For (5)
5
No opposing evidence
(2) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
6
1
MECH 6CLIN 1GENE 0EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
Early glycolytic reprogramming controls microglial…SupportingMECHJ Neuroinflamma… MEDIUM2021-PMID:34107997-
SIRT1 activation by Ligustrazine ameliorates migra…SupportingMECHPhytomedicine MEDIUM2024-PMID:39341123-
Paeoniflorin Inhibits the Activation of Microglia …SupportingCLINInt J Mol Sci MEDIUM2024-PMID:39684254-
Huangqi Guizhi Wuwu decoction promotes M2 microgli…SupportingMECHAging (Albany N… MEDIUM2023-PMID:37650573-
Alleviation of Microglia Mediating Hippocampal Neu…SupportingMECHCNS Neurosci Th… MEDIUM2025-PMID:40237232-
No claimOpposingMECH- MODERATE2026-PMID:41832672-
No claimOpposingMECH- MODERATE2026-PMID:41717780-
Legacy Card View — expandable citation cards

Supporting Evidence 5

Early glycolytic reprogramming controls microglial inflammatory activation. MEDIUM
J Neuroinflammation · 2021 · PMID:34107997
SIRT1 activation by Ligustrazine ameliorates migraine via the paracrine interaction of microglia and neurons. MEDIUM
Phytomedicine · 2024 · PMID:39341123
Paeoniflorin Inhibits the Activation of Microglia and Alleviates Depressive Behavior by Regulating SIRT1-NF-kB… MEDIUM
Paeoniflorin Inhibits the Activation of Microglia and Alleviates Depressive Behavior by Regulating SIRT1-NF-kB-NLRP3/Pyroptosis Pathway.
Int J Mol Sci · 2024 · PMID:39684254
Huangqi Guizhi Wuwu decoction promotes M2 microglia polarization and synaptic plasticity via Sirt1/NF-κB/NLRP3… MEDIUM
Huangqi Guizhi Wuwu decoction promotes M2 microglia polarization and synaptic plasticity via Sirt1/NF-κB/NLRP3 pathway in MCAO rats.
Aging (Albany NY) · 2023 · PMID:37650573
Alleviation of Microglia Mediating Hippocampal Neuron Impairments and Depression-Related Behaviors by Urolithi… MEDIUM
Alleviation of Microglia Mediating Hippocampal Neuron Impairments and Depression-Related Behaviors by Urolithin B via the SIRT1-FOXO1 Pathway.
CNS Neurosci Ther · 2025 · PMID:40237232

Opposing Evidence 2

No claim MODERATE
No claim MODERATE
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-10 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

I notice that while you've mentioned there should be literature provided above about circadian interventions and microglial priming, I don't see any specific research papers, PMIDs, or figure evidence in your prompt. The knowledge gap you've described is fascinating - exploring whether circadian interventions can reverse microglial priming independently of their effects on sleep disruption.

Let me generate novel therapeutic hypotheses based on the general understanding of circadian biology and microglial function, and then I can search for specific supporting evidence if needed:

Novel The

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

I'll provide a rigorous scientific critique of each hypothesis, focusing on identifying weaknesses, gaps in evidence, and alternative explanations.

Critical Evaluation of Therapeutic Hypotheses

1. Clock Gene-Mediated Microglial Reprogramming

Confidence: 0.75 → Revised: 0.35

Weaknesses:

  • Cell-type specificity gap: No evidence that BMAL1/CLOCK can be selectively targeted in microglia without affecting other brain cells or peripheral tissues
  • Compensation mechanisms ignored: CLOCK/BMAL1 knockout studies show compensatory pathways (NPAS2 can substitute for CLOCK)
  • **De

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

Clinical precedent:

  • Anti-TNF drugs have 20+ year safety record
  • IL-1 inhibitors approved and well-tolerated
Competitive advantage:
  • Chronotherapy approach could differentiate from continuous dosing
  • Lower overall drug exposure, potentially better safety
Timeline/Cost: 3-5 years, $200-500M (repurposing approved drugs)

7. Circadian Extracellular Matrix Remodeling

Druggability: MODERATE

Existing compounds:

  • MMP inhibitors: Marimastat (failed cancer trials), Batimastat (discontinued)
  • Hyaluronan therapies: Viscosupplementation products (orthopedics)

**H

Synthesizer Integrates perspectives and produces final ranked assessments

Price History

0.460.490.52 0.54 0.43 2026-04-212026-04-252026-04-28 Market PriceScoreevidencedebate 8 events
7d Trend
Stable
7d Momentum
▲ 7.4%
Volatility
High
0.0535
Events (7d)
7

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (7)

Early glycolytic reprogramming controls microglial inflammatory activation.
Journal of neuroinflammation (2021) · PMID:34107997
No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet

📅 Citation Freshness Audit

Freshness score = exp(-age×ln2/5): halves every 5 years. Green >0.6, Amber 0.3–0.6, Red <0.3.

No citation freshness data yet. Export bibliography — run scripts/audit_citation_freshness.py to populate.

📙 Related Wiki Pages (0)

No wiki pages linked to this hypothesis yet.

࢐ Browse all wiki pages

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

📊 Resource Economics & ROI

Moderate Efficiency Resource Efficiency Score
0.50
32.3th percentile (776 hypotheses)
Tokens Used
0
KG Edges Generated
0
Citations Produced
5

Cost Ratios

Cost per KG Edge
0.00 tokens
Lower is better (baseline: 2000)
Cost per Citation
0.00 tokens
Lower is better (baseline: 1000)
Cost per Score Point
0.00 tokens
Tokens / composite_score

Score Impact

Efficiency Boost to Composite
+0.050
10% weight of efficiency score
Adjusted Composite
0.505

How Economics Pricing Works

Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

📋 Reviews View all →

Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.

💬 Discussion

No DepMap CRISPR Chronos data found for SIRT1/PRKAA1/PPARGC1A.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for SIRT1/PRKAA1/PPARGC1A →
Loading history…

⚖️ Governance History

No governance decisions recorded for this hypothesis.

Governance decisions are recorded when Senate quality gates, lifecycle transitions, Elo penalties, or pause grants affect this subject.

Browse all governance decisions →

KG Entities (25)

ARNTLCLOCKCSNK1DCSNK1EHAS2IL1R1MMP9NFKB1NLRP3NR1D1NR1D2PER1PPARGC1APRKAA1SIRT1TNFRSF1Acircadian_clock_entrainmentcircadian_disruptionextracellular_matrixinflammatory_gene_expression

Related Hypotheses

Clock Gene-Mediated Microglial Reprogramming
Score: 0.455 | chronobiology
Circadian Extracellular Matrix Remodeling
Score: 0.455 | chronobiology
Temporal Cytokine Receptor Modulation
Score: 0.455 | chronobiology
Microglial-Specific Circadian Gene Therapy
Score: 0.455 | chronobiology
Light-Independent Chronopharmacology
Score: 0.455 | chronobiology

Estimated Development

Estimated Cost
$0
Timeline
0 months

🧪 Falsifiable Predictions

No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

Knowledge Subgraph (20 edges)

causes (2)

circadian_disruptionneuroinflammationcircadian_disruptionmicroglial_priming

inhibits (2)

NR1D1microglial_activationNR1D2microglial_activation

maintains (1)

MMP9microglial_priming

mediates (1)

IL1R1microglial_priming

modulates (5)

IL1R1positive_feedback_loopsTNFRSF1Apositive_feedback_loopsHAS2extracellular_matrixCSNK1Dcircadian_clock_entrainmentCSNK1Ecircadian_clock_entrainment

phosphorylates (1)

CSNK1DPER1

regulates (5)

SIRT1microglial_metabolismPRKAA1microglial_metabolismPPARGC1Amicroglial_metabolismARNTLinflammatory_gene_expressionCLOCKinflammatory_gene_expression

remodels (1)

MMP9extracellular_matrix

represses (1)

NR1D1NFKB1

transcriptionally regulates (1)

ARNTLNLRP3

Mechanism Pathway for SIRT1/PRKAA1/PPARGC1A

Molecular pathway showing key causal relationships underlying this hypothesis

graph TD
    ARNTL["ARNTL"] -->|transcriptionally| NLRP3["NLRP3"]
    NR1D1["NR1D1"] -->|represses| NFKB1["NFKB1"]
    IL1R1["IL1R1"] -->|mediates| microglial_priming["microglial_priming"]
    circadian_disruption["circadian_disruption"] -->|causes| neuroinflammation["neuroinflammation"]
    CSNK1D["CSNK1D"] -->|phosphorylates| PER1["PER1"]
    MMP9["MMP9"] -->|remodels| extracellular_matrix["extracellular_matrix"]
    IL1R1_1["IL1R1"] -->|modulates| positive_feedback_loops["positive_feedback_loops"]
    TNFRSF1A["TNFRSF1A"] -->|modulates| positive_feedback_loops_2["positive_feedback_loops"]
    circadian_disruption_3["circadian_disruption"] -->|causes| microglial_priming_4["microglial_priming"]
    SIRT1["SIRT1"] -->|regulates| microglial_metabolism["microglial_metabolism"]
    PRKAA1["PRKAA1"] -->|regulates| microglial_metabolism_5["microglial_metabolism"]
    PPARGC1A["PPARGC1A"] -->|regulates| microglial_metabolism_6["microglial_metabolism"]
    style ARNTL fill:#ce93d8,stroke:#333,color:#000
    style NLRP3 fill:#ce93d8,stroke:#333,color:#000
    style NR1D1 fill:#ce93d8,stroke:#333,color:#000
    style NFKB1 fill:#ce93d8,stroke:#333,color:#000
    style IL1R1 fill:#ce93d8,stroke:#333,color:#000
    style microglial_priming fill:#4fc3f7,stroke:#333,color:#000
    style circadian_disruption fill:#4fc3f7,stroke:#333,color:#000
    style neuroinflammation fill:#4fc3f7,stroke:#333,color:#000
    style CSNK1D fill:#ce93d8,stroke:#333,color:#000
    style PER1 fill:#ce93d8,stroke:#333,color:#000
    style MMP9 fill:#ce93d8,stroke:#333,color:#000
    style extracellular_matrix fill:#81c784,stroke:#333,color:#000
    style IL1R1_1 fill:#ce93d8,stroke:#333,color:#000
    style positive_feedback_loops fill:#4fc3f7,stroke:#333,color:#000
    style TNFRSF1A fill:#ce93d8,stroke:#333,color:#000
    style positive_feedback_loops_2 fill:#4fc3f7,stroke:#333,color:#000
    style circadian_disruption_3 fill:#4fc3f7,stroke:#333,color:#000
    style microglial_priming_4 fill:#4fc3f7,stroke:#333,color:#000
    style SIRT1 fill:#ce93d8,stroke:#333,color:#000
    style microglial_metabolism fill:#4fc3f7,stroke:#333,color:#000
    style PRKAA1 fill:#ce93d8,stroke:#333,color:#000
    style microglial_metabolism_5 fill:#4fc3f7,stroke:#333,color:#000
    style PPARGC1A fill:#ce93d8,stroke:#333,color:#000
    style microglial_metabolism_6 fill:#4fc3f7,stroke:#333,color:#000

3D Protein Structure

🧬 SIRT1 — PDB 4KXQ Click to expand 3D viewer

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll | Reset: right-click

Source Analysis

Can circadian interventions reverse microglial priming independent of sleep disruption effects?

chronobiology | 2026-04-08 | completed

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Same Analysis (5)

Clock Gene-Mediated Microglial Reprogramming
Score: 0.46 · ARNTL/CLOCK
Circadian Extracellular Matrix Remodeling
Score: 0.46 · MMP9/HAS2
Temporal Cytokine Receptor Modulation
Score: 0.46 · IL1R1/TNFRSF1A
Microglial-Specific Circadian Gene Therapy
Score: 0.46 · ARNTL
Light-Independent Chronopharmacology
Score: 0.46 · CSNK1D/CSNK1E
→ View all analysis hypotheses
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.